carpal tunnel syndrome, trigger finger, amyloid deposition, cardiac amyloidosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who underwent surgery for carpal tunnel syndrome or trigger finger at Saiseikai Yamaguchi General Hospital from February 2020 onward. Patients with amyloid deposition confirmed by pathological examination of tissue collected during surgery. Patients judged to be negative for cardiac amyloidosis at the time of surgery based on cardiovascular evaluation. Patients who can be contacted at the time of the 5-year follow-up evaluation. Patients from whom informed consent for participation in this study can be obtained
Exclusion criteria
Exclusion criteria: Patients who do not give their consent to participate in the study Patients for whom it is difficult to obtain the information required for the 5-year follow-up or to carry out the necessary tests Patients deemed unsuitable by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of conversion to cardiac amyloidosis at the five-year follow-up assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Comparison of the positivity rate between cases of carpal tunnel syndrome and trigger finger 2. Association between positivity and clinical factors such as age, gender, bilateral involvement, involvement of multiple fingers, and spinal stenosis 3. Association between the location and subtype of amyloid deposits at the time of surgery and positivity at the 5-year follow-up 4. Echocardiographic findings, biomarkers, and distribution of 99mTc-PYP myocardial scintigraphy uptake at the 5-year follow-up | — |
Countries
Japan
Contacts
Saiseikai Yamaguchi General Hospital Department of Orthopedic Surgery